Alpha-7 nicotinic acetylcholine receptor
β
Henrik H. Hansen; Daniel B. Timmermann; Dan Peters; Carrie Walters; M. Imad Dama
π
Article
π
2007
π
John Wiley and Sons
π
English
β 386 KB
It is considered that activation of nicotinic a 7 receptors (a 7 nAChR) is useful for the treatment of cognitive disturbances in schizophrenia and Alzheimer's disease. Recently, selective a 7 nAChR agonists have been discovered and are used to validate the a 7 nAChR as a drug target for the treatmen